Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc

Bullboard Posts

Post by grosdavidon Apr 20, 2020 9:44am

193 Views

Post# 30929136

AGN wants to start running, that push to 0,40$

Was quick....

Honnestly, the facts were all layed on this board last week. As i mentionned yesterday, for the new ones, go read the article on PennyStocks that indicates an STOCK ALERT on AGN.

This week we could see positive updates and new advancements in South Korea. I truly feel the solution starts from that country. Look at their charts of death/cases, it is INCREDIBLY LOW.

The best is yet to come, once this launches, look at all the new investors from SONA, BLR, DM coming to AGN for the COVID19 solution.

Cheers
David

Link to PennyStocks' stock alert on AGN only.

https://pennystocks.com/penny-stock-sectors/biotech-stocks/2020/04/19/biggest-market-opportunity-in-2020-coronavirus-penny-stocks/